New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 6, 2013
18:36 EDTALNYAlnylam aims to advance ALN-TTR02 into Phase III pivotal trial
Alnylam aims to advance ALN-TTR02 into Phase III pivotal trial in Transthyretin, TTR -mediated amyloidosis, ATTR, Patients with Familial Amyloidotic Polyneuropathy, FAP, by late 2013; Phase II data expected in mid-2013.
News For ALNY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 27, 2015
09:58 EDTALNYOn The Fly: Analyst Initiation Summary
Subscribe for More Information
06:59 EDTALNYAlnylam initiated with an Outperform at Cowen
Subscribe for More Information
February 23, 2015
07:22 EDTALNYSunTrust to hold a conference
2015 Biotechnology and Pharmaceutical 1:1 Orphan Drug Day is being held in New York on February 23.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use